Handa Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
April 28, 2022 at 02:37 am IST
Handa Pharmaceuticals, Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was TWD 29.24 million compared to TWD 28.86 million a year ago. Revenue was TWD 29.24 million compared to TWD 28.86 million a year ago. Net loss was TWD 247.67 million compared to TWD 282.1 million a year ago. Basic loss per share from continuing operations was TWD 2.1 compared to TWD 2.44 a year ago. Diluted loss per share from continuing operations was TWD 2.1 compared to TWD 2.44 a year ago.